Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Exercise/Conversion of 16,141 MAZE shares, $168.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 16,141 | $168.2K |
| Sep 8, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 9,705 | $254.5K |
| Sep 4, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 4,481 | $118.2K |
| Sep 3, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 16,141 | $168.2K |
| Aug 14, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 16,142 | $168.2K |
| Jul 2, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 14,609 | $152.2K |
| Jun 3, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 14,853 | $154.8K |
| May 18, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 15,000 | $156.3K |
| Apr 2, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 15,000 | $156.3K |
| Mar 20, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 15,000 | $156.3K |